Body
Hamilton, ON (February 12, 2020) - A new group of antibiotics with a unique approach to attacking bacteria has been discovered, making it a promising clinical candidate in the fight against antimicrobial resistance.
The newly-found corbomycin and the lesser-known complestatin have a never-before-seen way to kill bacteria, which is achieved by blocking the function of the bacterial cell wall. The discovery comes from a family of antibiotics called glycopeptides that are produced by soil bacteria.
CLEVELAND, Ohio (February 12, 2020)--Skeletal muscle mass and strength are critical in helping prevent falls, fractures, and disability. Yet, they continue to decline during the menopause transition. A new study showed that the prolonged use (defined as ≥13 mo) of hormone therapy (HT) was associated with higher muscle mass and less chance of sarcopenia. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
The discovery identifies an adaptation by cancer cells that facilitates their spreading to distant sites, and the potential for targeting these features to prevent or slow the progression of metastatic hormone receptor-positive breast cancer.
New Rochelle, NY, February 12, 2020--A new study has shown that gene therapy to treat one of the most common hereditary disorders, aldehyde dehydrogenase type 2 (ALDH2) deficiency, may prevent increased risk for esophageal cancer and osteoporosis associated with chronic alcohol exposure. The study, performed in a mouse model of ALDH2, is published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Study shows increased hand hygiene at top 10 airports can reduce spread of coronavirus by 37 percent
As coronavirus spreads across the globe via infected air travelers, authorities are attempting to contain the outbreak and avoid a pandemic. A study published in Risk Analysis analyzes the impact of implementing disease mitigation strategies at airports across the globe. The study finds that increasing traveler engagement with proper hand-hygiene at all airports has the potential to reduce the risk of a potential pandemic by 24-69 percent.
DALLAS, Feb. 12, 2020 -- Damaged small blood vessels in the eye may be a marker for increased stroke risk among people with diabetes, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2020 - Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
DALLAS, Feb. 12, 2020 -- Shingles, a viral infection caused by the chickenpox virus, is linked to an increased risk of stroke. A new study found that Zoster Vaccine Live, one type of shingles vaccination, may prevent some older adults from having a stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2020 - Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
DALLAS, Feb. 12, 2020 -- Regularly golfing - at least once per month - was found to lower the risk of death among older adults, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2020 - Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
DALLAS, Feb. 12, 2020 -- In patients unable to have the clots that caused their stroke dissolved or removed, a promising new stimulation treatment that increases blood flow to the brain may become an option, according to two preliminary studies to be presented at the American Stroke Association's International Stroke Conference 2020 - Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
DALLAS, Feb. 12, 2020 -- Seizures may be linked to a higher risk of death or disability in adults who have had a severe ischemic stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2020 - Feb. 19-21 in Los Angeles, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
CLEVELAND, Ohio (February 12, 2020)--Lumbar disc degeneration and resulting lower back pain become greater concerns with age and disproportionately affect women more than men, likely as a result of decreasing estrogen levels during menopause. A new study demonstrates that vitamin D deficiency, smoking, high body mass index (BMI), and osteoporosis are risk factors for greater back pain. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
A tiny molecule of RNA - known as 'micro RNA' - plays a key role in 'rewiring' cancer cells so they can resist the effects of chemotherapy, a new study reveals.
The discovery opens up the possibility of creating new cancer drugs that target this micro RNA molecule, rather than more conventional treatments that block the action of proteins.
Scientists at The Institute of Cancer Research, London, found that a type of micro RNA known as MIR1249 plays a key role in allowing bile duct cancers to resist chemotherapy.
Sarah, a military veteran living on the coast of South Carolina, knew she had a problem. The opioids prescribed for her pain were becoming a headache of their own.
"We trust our doctors. I went to my pain management doctor and said, 'I feel like I'm getting addicted to this. We have a problem. I'm waking up sick.' And instead of decreasing my medication, he just added another medication on top of it."
Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects.
MRSA bloodstream infections have a mortality rate between 20 and 25 per cent and cause around 1000 infections a year in Australia.
WEST LAFAYETTE, Ind. - One in three adults aged 60 and over suffering from a hip fracture dies within one year. Now, a Purdue University-affiliated startup is moving closer to the start of clinical trials for a novel injectable drug that is targeted to heal broken bones faster and strengthen weak bones.
The Purdue University discovered drug, NOV004, from Novosteo Inc. is unique in that it concentrates at the fracture site while reducing exposure to the rest of the body.